IgG subclass deficiency associated with corticosteroids in obstructive lung disease

Area of Science:

• Immunology
• Pulmonology
• Clinical Medicine

Background:

• Obstructive airways diseases (OAD) like asthma and chronic bronchitis are frequently associated with recurrent sinopulmonary infections.
• The role of immunoglobulin G (IgG) subclass deficiencies in the pathogenesis of these infections, particularly in relation to corticosteroid therapy, remains unclear.

Purpose of the Study:

• To investigate the relationship between IgG subclass levels, chronic corticosteroid use, and the incidence of recurrent sinopulmonary infections in adult patients with OAD.
• To determine if IgG subclass deficiencies are secondary to corticosteroid treatment in these patient groups.

Main Methods:

• Measurement of IgG subclass levels (IgG1, IgG2, IgG3, IgG4) in three distinct groups of adult patients with OAD.
• Group 1: Corticosteroid-dependent bronchial asthma.
• Group 2: Corticosteroid-dependent chronic bronchitis/emphysema.
• Group 3: Asthma patients with recurrent sinopulmonary infections not requiring oral corticosteroids.

Main Results:

• IgG subclass deficiencies were observed in 66.7% of group 1, 46.7% of group 2, and 6.7% of group 3.
• Significant differences in IgG subclass deficiencies were found between corticosteroid-treated groups (1 and 2) and the non-corticosteroid group (3).
• IgG1 deficiency was the most prevalent, identified in 77.8% of patients with any IgG subclass deficiency.

Conclusions:

• IgG subclass deficiencies are common in adult patients with obstructive airways disease requiring chronic corticosteroid therapy.
• These deficiencies, particularly IgG1, appear to be secondary to long-term corticosteroid use, potentially contributing to recurrent sinopulmonary infections.
• Further research is warranted to explore the clinical implications and management strategies for IgG subclass deficiencies in this patient population.